TY - JOUR
T1 - Nonoperative and Arthroscopic Approaches to the Postmeniscectomy Arthritic Knee
AU - Shaffer, Benjamin
AU - Hanypsiak, Bryan
N1 - Funding Information:
So do supplements work? Well, in the laboratory and in animal models, they certainly seem to stimulate production of cartilage-building proteins and inhibit degradation by enzymes. However, do they truly provide a protective role? Currently, a large multicenter study jointly sponsored by the National Institutes of Health National Center for Complementary and Alternative Medicine and the National Institute of Arthritis and Musculoskeletal Skin Diseases is attempting to answer this question. Known as the GCIT (Glucosamine Chondroitin Intervention Trial), this study is intended to test the effectiveness of these supplements in decreasing symptoms and their protective influence on articular cartilage in a large group of patients. Final results are expected in 2005.
PY - 2003/12
Y1 - 2003/12
N2 - Management of the unicompartmental osteoarthritic knee is challenging. Recent treatment modalities, including NSAIDs, supplements, and injectable HA, have provided clinically effective adjuncts. Supplements seem to be most effective in treating mild to moderate OA. Wide product variability mandates familiarization by healthcare providers. The widely advertised "chondroprotective" benefit has not been convincingly proven and awaits further outcome studies. Hyaluronic acid seems to be clinically effective in patients with mild to moderate osteoarthritis and has a low complication rate. Its effectiveness, however, is probably not achieved through its marketed "viscosupplementation" mechanism. Further research will allow us to better determine its exact placement in the treatment of osteoarthritis. In the future, the treatment of osteoarthritis will most likely focus on prevention, and biologic manipulation such as gene therapy may eventually render even today's "advanced" therapeutic alternatives obsolete.
AB - Management of the unicompartmental osteoarthritic knee is challenging. Recent treatment modalities, including NSAIDs, supplements, and injectable HA, have provided clinically effective adjuncts. Supplements seem to be most effective in treating mild to moderate OA. Wide product variability mandates familiarization by healthcare providers. The widely advertised "chondroprotective" benefit has not been convincingly proven and awaits further outcome studies. Hyaluronic acid seems to be clinically effective in patients with mild to moderate osteoarthritis and has a low complication rate. Its effectiveness, however, is probably not achieved through its marketed "viscosupplementation" mechanism. Further research will allow us to better determine its exact placement in the treatment of osteoarthritis. In the future, the treatment of osteoarthritis will most likely focus on prevention, and biologic manipulation such as gene therapy may eventually render even today's "advanced" therapeutic alternatives obsolete.
UR - http://www.scopus.com/inward/record.url?scp=0346850587&partnerID=8YFLogxK
U2 - 10.1016/j.arthro.2003.09.051
DO - 10.1016/j.arthro.2003.09.051
M3 - Article
C2 - 14673431
AN - SCOPUS:0346850587
SN - 0749-8063
VL - 19
SP - 122
EP - 128
JO - Arthroscopy - Journal of Arthroscopic and Related Surgery
JF - Arthroscopy - Journal of Arthroscopic and Related Surgery
IS - 10 SUPPL. 1
ER -